Together, these findings demonstrate a potential role for the manipulation of SOCS3 levels to regulate ALS progression, which may uncover a promising and novel potential therapeutic target for balancing an uncontrolled inflammatory response. The gene discussed is SOCS3; the disease is amyotrophic lateral sclerosis.